Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 1.000 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.519 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.512 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.507 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.507 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.507 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.496 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.494 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.494 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.494 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.493 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.488 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.488 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.484 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.479 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.477 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.477 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.476 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.476 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.474 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.473 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.472 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.471 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.468 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.467 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.467 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.467 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.466 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.459 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
| 1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.456 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.455 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.452 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.449 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.448 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.447 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.445 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.443 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 |